Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Devising Targeted Therapies Against VEXAS Syndrome by Untangling the Vicious Interplay of Inflammation and Clonal Dominance

NCT07746986 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07746986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Devising Targeted Therapies Against VEXAS Syndrome by Untangling the Vicious Interplay of Inflammation and Clonal Dominance
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
May 31, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vexas